Diabetes Diagnostics Market
Diabetes Diagnostics Market Size, Share Analysis by Product (Biochips, Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors), by End-User (Hospitals, Clinics, Diagnostics Centers, Homecare Settings)- Global Market Insights 2020 to 2030
Analysis of Diabetes Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Diabetes Diagnostics Market: About the Report
Demand for diabetes diagnostics is expected to rise in response to surging hospitalizations amid the COVID-19 surge. Studies identifying diabetics at higher risk of getting critically ill if infected by the virus are fuelling demand for various related products, including diabetes test strips.
Fact.MR, in its recent report, has projected that demand from hospitals will continue increasing through the forecast period from 2020 and 2030. Government funding towards building hospitals to make healthcare better accessible in rural areas will aid overall expansion of the market. North America, Asia Pacific, and Europe will be attractive regions for players in the global diabetes diagnostics market through 2030.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Diabetes Diagnostics Market Overview
Driven by the increasing incidence of diabetes, the global diabetes diagnostics market is exhibiting notable growth. According to the World Health Organization (WHO), 422 million people around the world have diabetes. Prevalence of diabetes is higher in low- and middle-income countries, as per the WHO’s findings. Besides this, diabetes also is identified as a principal reason behind rising kidney failure, blindness, heart attacks, stroke, and lower limb amputation cases.
According to Fact.MR, the rising incidence of diabetes is expected to fuel the demand for better-performance and smarter diabetes diagnostics to increase significantly between 2020 and 2030.As per the WHO, globally, over 1.9 billion adults aged 18 years and older were overweight in 2016.
Of these, more than 650 million adults were obese. Obesity is known to be one of the key conditions that can lead to diabetes. Higher prevalence of obesity will therefore stoke growth opportunities for the diabetes diagnostics market.
Advent of Nanotechnology Propelling Growth
Nanotechnology is at the forefront of technologies that are forecast to offer a reliable methodology in the early and precise diagnosis and treatment of diabetes. Several benefits of nanotechnology, such as drug release control and target specification, are driving experts to develop advanced glucose detection and insulin delivery methods using nanotechnology. Such advancements are likely to boost the growth of the global diabetes diagnostics market.
Nanotechnology gives access to advanced sensing technologies to provide timely and more accurate information on diabetes. A pair of researchers from the Oregon State University College of Engineering developed means to print transistor-based glucose sensors onto a catheter attached to a wearable pump. This technology allowed diabetics to program the pump to deliver glucagon and insulin at precise doses and time.
A slew of studies similar the one mentioned are undertaken in the last few years to study the use of nanotechnology in diabetes. A common aim of these researches is to offer timely and accurate diagnosis. Spurred by this, the diabetes diagnostics market will exhibit significant growth over the coming years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Lack of Awareness Limiting Market Growth
The diabetes diagnostics market is hampered by lack of awareness about diabetes and its effects. In 2015, according to UK National Health Service (NHS), nearly 3.9 million people were diagnosed with diabetes, and more than 590,000 people were unaware and undiagnosed. This might restrict the overall growth opportunities for the market.
Regional Outlook of Diabetes Diagnostics Market
North America is one of the most attractive markets for diabetes diagnostics. Rising healthcare expenditure is one of the biggest factors accountable for the region's exceptional growth. For instance, in 2019, Canada's per-capita spending on health ranked 11th amongst health-care systems in the Organization for Economic Co-operation and Development (OECD).
Besides this, increasing Food and Drug Administration (FDA) approvals to some of the leading market players in countries such as the U.S. and Canada are also boosting the growth of the diabetes diagnostics market in North America. For instance, in February 2020, Abbott obtained FDA permission for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals and clinics.
Asia Pacific has also emerged as a lucrative market for diabetes diagnostics. Rising diabetic population in economies such as China and India is driving growth in the region. Increasing government funds, initiatives, and education on health awareness are further augmenting the demand for diabetes diagnostics in the region.
For instance, the New Rural Co-operative Medical Care System (NRCMCS) is intended at making the healthcare system more affordable for rural people in China. It covered nearly 98% of rural residents in 2018. Such initiatives towards the developing healthcare sector in underdeveloped areas of the developing countries are promoting diabetes diagnostics market growth.
Besides North America and Asia Pacific, Europe accounts for a sizeable share of the global diabetes diagnostics market. Growth witnessed in the region is primarily due to the growing diabetes cases in the region. According to the WHO, deaths caused due to diabetes are expected to double by 2030 as compared to 2005.
Furthermore, increasing projects towards the expansion of healthcare are likely to augment market growth. For instance, the NOVEL project is intended to transform healthcare in Europe. The European Union's Horizon 2020 funded the NOBEL Coordination and Support Action. Such projects are expected to fuel demand for smarter diabetes diagnostics during the forecast period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Diabetes Diagnostics Market Insights by Product
According to Fact.MR, the test strips segment is forecast to witness surging demand during the assessment period, in terms of product in the diabetes diagnostics market space. Test strips manufacturers are increasingly launching low-cost products. Besides this, rising investment is propelling growth within the segment.
For instance, In June 2018, LaunchByte, an investment company, invested in StripSupply, a Boston-based blood glucose testing Product Company. This investment helped StipSupply in stimulating the development of low-cost test strips, and their production and sales.
Besides this, the continuous glucose monitors (CGM) segment is also expected to showcase noteworthy growth owing to the development of smarter CGMs. Moreover, the growing interest of players in collaborations is also supporting the growth of this segment. For instance, Medtronic Plc partnered with Eris Lifesciences to produce a smart continuous glucose monitoring system in January 2019.
Diabetes Diagnostics Market Insights by End User
Based on end user, hospitals are likely to account for a sizeable share of the market in terms of market value. Growing number of hospitals and the rising number of facilities across the world are key factors behind the growth of this segment.
Besides, rising government expenditure on healthcare is augmenting the demand for diabetes diagnostics in hospitals and among other end users. For instance, according to National Health Expenditure Accounts (NHEA), health care spending in the U.S. grew 4.6 percent in 2019 and reached $3.8 trillion or $11,582 per person. Such rising spending coupled with increasing healthcare awareness is driving more patients to diabetes diagnosis, which is benefitting the market.
Diabetes Diagnostics Market: Competitive Landscape
The market for diabetes diagnostics is getting extremely competitive owing to the rising cases of around the world and increasing willingness among patients to spend on advanced healthcare. With rising number of new entrants in the diabetes diagnostics market, established players are focusing on technological advancement and frequent new product launches to maintain their positions.
For instance, in June 2018, Senseonics gained FDA's permission for its Implantable Eversense Continuous Glucose Monitoring (CGM) system in the US. This long-term system is one of the major discoveries of diabetes devices. The device monitors blood glucose levels for 90 days without the use of lancets and is gaining immense popularity among patients.
Besides this, leading players are focusing on collaborations to expand their regional footprint. For instance, in January 2020, LifeScan, a US-based company entered into collaboration with DKSH, a company specialized in market expansion services, especially in Asia Pacific. With this partnership, DKSH will provide supervisory assistance and distribution and logistics for the sales of LifeScan products in other countries such as Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.
Some of the leading players operating in the diabetes diagnostics market include
- Medtronic plc
- Abbott Laboratories
- F.Hoffmann-La-Ltd.
- Bayer AG
- Lifescan, Inc.
- B Braun Melsungen AG
- Lifescan, Inc.
- Dexcom Inc.
- Insulet Corporation
- Ypsomed Holdings
- Companion Medical
- Sanofi
- Valeritas Holding Inc.
- Novo Nordisk
- Arkray, Inc.
The Analyst's Viewpoint
Companies operating in the market are seeking out opportunities to expand footprint across East and South Asia. As a result they are focusing on launching affordable diabetes supplies to gain competitive edge. Besides this, rising incidence of diabetes will continue supporting the expansion of the market in the region.
Diabetes Diagnostics Market: Segmentation
Fact.MR has studied the diabetes diagnostics market with detailed segmentation on the basis of by product type, end user, and key region.
-
By Product:
- Biochips
- Test Strips
- Lancets
- Analog Glucose Monitors
- Continuous Glucose Monitors
-
By End User:
- Hospitals
- Clinics
- Diagnostics Centers
- Homecare Settings
-
By Region:
- North America
- Europe
- Latin America
- Middle East & Africa
- Oceania
- East Asia
- South Asia
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Market Context
- 5. Market Background
- 6. Global Market Volume (‘000’ Units) Analysis 2015 to 2019 and Forecast, 2020 to 2030
- 7. Global Market Pricing Analysis
- 8. Global Market Demand Value or Size (US$ Mn) Analysis 2015 to 2019 and Forecast, 2020 to 2030
- 9. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, By Product
- 9.1. Test Strips
- 9.2. Lancets
- 9.3. Analog Glucose Monitors
- 9.4. Continuous Glucose Monitors
- 10. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, By End User
- 10.1. Hospitals
- 10.2. Clinics
- 10.3. Diagnostic Centers
- 10.4. Homecare settings
- 11. Global Market Analysis 2015 to 2019 and Forecast 2020 to 2030, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 13. Latin America Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 14. Europe Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 15. South Asia Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 16. East Asia Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 17. Oceania Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 18. Middle East and Africa Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 19. Emerging & Key Countries Market Analysis 2015 to 2019 and Forecast 2020 to 2030
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. Abbott Laboratories
- 21.2. Becton Dickinson & Company
- 21.3. F. Hoffmann-La Roche AG
- 21.4. Medtronic PLC
- 21.5. B Braun Melsungen AG
- 21.6. DexCom Inc.
- 21.7. Bayer Corporation
- 21.8. Insulet Corporation
- 21.9. Ypsomed Holding AG
- 21.10. Sanofi
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Global Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 04: Global Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 05: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
Table 06: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Region
Table 07: North America Market Value (US$ Mn) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Country
Table 08: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 09: North America Market Volume ('000' Units) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Product
Table 10: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
Table 11: Latin America Market Value (US$ Mn) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Country
Table 12: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 13: Latin America Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 14: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
Table 15: Europe Market Value (US$ Mn) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Country
Table 16: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 17: Europe Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 18: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
Table 19: South Asia Market Value (US$ Mn) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Country
Table 20: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 21: South Asia Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 22: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
Table 23: East Asia Market Value (US$ Mn) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Country
Table 24: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 25: East Asia Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 26: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
Table 27: Oceania Market Value (US$ Mn) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Country
Table 28: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 29: Oceania Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 30: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
Table 31: Middle East and Africa Market Value (US$ Mn) Analysis 2015 to 2019 and Forecast 2020 to 2030, By Country
Table 32: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 33: Middle East and Africa Market Volume ('000' Units) Analysis and Opportunity Assessment 2015 to 2030, By Product
Table 34: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2015 to 2030, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Healthcare Expenditure in US$ Tn (2013 to 2020)
Figure 02: Global Market Volume ('000' Units) Analysis, 2015 to 2019
Figure 03: Global Market Volume Forecast ('000' Units), 2020 to 2030
Figure 04: Test Strips Pricing Analysis (US$), By Region, 2019
Figure 05: Lancets Pricing Analysis (US$), By Region, 2019
Figure 06: Analog Glucose Monitors Pricing Analysis (US$), By Region, 2019
Figure 07: Continuous Glucose Monitors Pricing Analysis (US$), By Region, 2019
Figure 08: Global Market Value Analysis (US$ Mn), 2015 to 2019
Figure 09: Global Market Value Forecast (US$ Mn), 2020 to 2030
Figure 10: Global Market Absolute $ Opportunity, 2020 - 2030
Figure 11: Global Market Share Analysis (%), By Product, 2020 to 2030
Figure 12: Global Market Y-o-Y Analysis (%), By Product, 2020 to 2030
Figure 13: Global Market Attractiveness Analysis By Product, 2020 to 2030
Figure 14: Global Market Share Analysis (%), By End User, 2020 to 2030
Figure 15: Global Market Y-o-Y Analysis (%), By End User, 2020 to 2030
Figure 16: Global Market Attractiveness Analysis by End User, 2020 to 2030
Figure 17: Global Market Share Analysis (%), By Region, 2020 to 2030
Figure 18: Global Market Y-o-Y Analysis (%), By Region, 2020 to 2030
Figure 19 Global Market Attractiveness Analysis by Region, 2020 to 2030
Figure 20: North America Market Value Share, By Product, 2020 (E)
Figure 21: North America Market Value Share, By End User, 2020 (E)
Figure 22: North America Market Value Share, By Country, 2020 (E)
Figure 23: North America Market Value Analysis (US$ Mn), 2015 to 2019
Figure 24: North America Market Value Forecast (US$ Mn), 2020 to 2030
Figure 25: North America Market Attractiveness Analysis By Product , 2020 to 2030
Figure 26: North America Market Attractiveness Analysis by End User, 2020 to 2030
Figure 27: North America Market Attractiveness Analysis by Country, 2020 to 2030
Figure 28: Latin America Market Value Share, By Product, 2020 (E)
Figure 29: Latin America Market Value Share, By End User, 2020 (E)
Figure 30: Latin America Market Value Share, By Country, 2020 (E)
Figure 31: Latin America Market Value Analysis (US$ Mn), 2015 to 2019
Figure 32: Latin America Market Value Forecast (US$ Mn), 2020 to 2030
Figure 33: Latin America Market Attractiveness Analysis By Product , 2020 to 2030
Figure 34: Latin America Market Attractiveness Analysis by End User, 2020 to 2030
Figure 35: Latin America Market Attractiveness Analysis by Country, 2020 to 2030
Figure 36: Europe Market Value Share, By Product, 2020 (E)
Figure 37: Europe Market Value Share, By End User, 2020 (E)
Figure 38: Europe Market Value Share, By Country, 2020 (E)
Figure 39: Europe Market Value Analysis (US$ Mn), 2015 to 2019
Figure 40: Europe Market Value Forecast (US$ Mn), 2020 to 2030
Figure 41: Europe Market Attractiveness Analysis By Product , 2020 to 2030
Figure 42: Europe Market Attractiveness Analysis by End User, 2020 to 2030
Figure 43: Europe Market Attractiveness Analysis by Country, 2020 to 2030
Figure 44: South Asia Market Value Share, By Product, 2020 (E)
Figure 45: South Asia Market Value Share, By End User, 2020 (E)
Figure 46: South Asia Market Value Share, By Country, 2020 (E)
Figure 47: South Asia Market Value Analysis (US$ Mn), 2015 to 2019
Figure 48: South Asia Market Value Forecast (US$ Mn), 2020 to 2030
Figure 49: South Asia Market Attractiveness Analysis By Product , 2020 to 2030
Figure 50: South Asia Market Attractiveness Analysis by End User, 2020 to 2030
Figure 51: South Asia Market Attractiveness Analysis by Country, 2020 to 2030
Figure 52: East Asia Market Value Share, By Product, 2020 (E)
Figure 53: East Asia Market Value Share, By End User, 2020 (E)
Figure 54: East Asia Market Value Share, By Country, 2020 (E)
Figure 55: East Asia Market Value Analysis (US$ Mn), 2015 to 2019
Figure 56: East Asia Market Value Forecast (US$ Mn), 2020 to 2030
Figure 57: East Asia Market Attractiveness Analysis By Product , 2020 to 2030
Figure 58: East Asia Market Attractiveness Analysis by End User, 2020 to 2030
Figure 59: East Asia Market Attractiveness Analysis by Country, 2020 to 2030
Figure 60: Oceania Market Value Share, By Product, 2020 (E)
Figure 61: Oceania Market Value Share, By End User, 2020 (E)
Figure 62: Oceania Market Value Share, By Country, 2020 (E)
Figure 63: Oceania Market Value Analysis (US$ Mn), 2015 to 2019
Figure 64: Oceania Market Value Forecast (US$ Mn), 2020 to 2030
Figure 65: Oceania Market Attractiveness Analysis By Product , 2020 to 2030
Figure 66: Oceania Market Attractiveness Analysis by Country, 2020 to 2030
Figure 67: Middle East and Africa Market Value Share, By Product, 2020 (E)
Figure 68: Middle East and Africa Market Value Share, By End User, 2020 (E)
Figure 69: Middle East and Africa Market Value Share, By Country, 2020 (E)
Figure 70: Middle East and Africa Market Value Analysis (US$ Mn), 2015 to 2019
Figure 71: Middle East and Africa Market Value Forecast (US$ Mn), 2020 to 2030
Figure 72: Middle East and Africa Market Attractiveness Analysis By Product , 2020 to 2030
Figure 73: Middle East and Africa Market Attractiveness Analysis by End User, 2020 to 2030
Figure 74: MEA Market Attractiveness Analysis by Country, 2020 to 2030
Figure 75: U.S. Market Value Analysis (US$ Mn), 2020 & 2030
Figure 76: U.S. Market Value Share, By Product, 2020 (E)
Figure 77: U.S. Market Value Share, By End User, 2020 (E)
Figure 78: Canada Market Value Analysis (US$ Mn), 2020 & 2030
Figure 79: Canada Market Value Share, By Product, 2020 (E)
Figure 80: Canada Market Value Share, By End User, 2020 (E)
Figure 81: Mexico Market Value Analysis (US$ Mn), 2020 & 2030
Figure 82: Mexico Market Value Share, By Product, 2020 (E)
Figure 83: Mexico Market Value Share, By End User, 2020 (E)
Figure 84: Brazil Market Value Analysis (US$ Mn), 2020 & 2030
Figure 85: Brazil Market Value Share, By Product, 2020 (E)
Figure 86: Brazil Market Value Share, By End User, 2020 (E)
Figure 87: Germany Market Value Analysis (US$ Mn), 2020 & 2030
Figure 88: Germany Market Value Share, By Product, 2020 (E)
Figure 89: Germany Market Value Share, By End User, 2020 (E)
Figure 90: U. K. Market Value Analysis (US$ Mn), 2020 & 2030
Figure 91: U. K. Market Value Share, By Product, 2020 (E)
Figure 92: U. K. Market Value Share, By End User, 2020 (E)
Figure 93: France Market Value Analysis (US$ Mn), 2020 & 2030
Figure 94: France Market Value Share, By Product, 2020 (E)
Figure 95: France Market Value Share, By End User, 2020 (E)
Figure 96: Italy Market Value Analysis (US$ Mn), 2020 & 2030
Figure 97: Italy Market Value Share, By Product, 2020 (E)
Figure 98: Italy Market Value Share, By End User, 2020 (E)
Figure 99: Spain Market Value Analysis (US$ Mn), 2020 & 2030
Figure 100: Spain Market Value Share, By Product, 2020 (E)
Figure 101: Spain Market Value Share, By End User, 2020 (E)
Figure 102: Russia Market Value Analysis (US$ Mn), 2020 & 2030
Figure 103: Russia Market Value Share, By Product, 2020 (E)
Figure 104: Russia Market Value Share, By End User, 2020 (E)
Figure 105: China Market Value Analysis (US$ Mn), 2020 & 2030
Figure 106: China Market Value Share, By Product, 2020 (E)
Figure 107: China Market Value Share, By End User, 2020 (E)
Figure 108: Japan Market Value Analysis (US$ Mn), 2020 & 2030
Figure 109: Japan Market Value Share, By Product, 2020 (E)
Figure 110: Japan Market Value Share, By End User, 2020 (E)
Figure 111: South Korea Market Value Analysis (US$ Mn), 2020 & 2030
Figure 112: South Korea Market Value Share, By Product, 2020 (E)
Figure 113: South Korea Market Value Share, By End User, 2020 (E)
Figure 114: India Market Value Analysis (US$ Mn), 2020 & 2030
Figure 115: India Market Value Share, By Product, 2020 (E)
Figure 116: India Market Value Share, By End User, 2020 (E)
Figure 117: Thailand Market Value Analysis (US$ Mn), 2020 & 2030
Figure 118: Thailand Market Value Share, By Product, 2020 (E)
Figure 119: Thailand Market Value Share, By End User, 2020 €
Figure 120: Malaysia Market Value Analysis (US$ Mn), 2020 & 2030
Figure 121: Malaysia Market Value Share, By Product, 2020 (E)
Figure 122: Malaysia Market Value Share, By End User, 2020 €
Figure 123: Indonesia Market Value Analysis (US$ Mn), 2020 & 2030
Figure 124: Indonesia Market Value Share, By Product, 2020 (E)
Figure 125: Indonesia Market Value Share, By End User, 2020 €
Figure 126: Australia Market Value Analysis (US$ Mn), 2020 & 2030
Figure 127: Australia Market Value Share, By Product, 2020 (E)
Figure 128: Australia Market Value Share, By End User, 2020 €
Figure 129: New Zealand Market Value Analysis (US$ Mn), 2020 & 2030
Figure 130: New Zealand Market Value Share, By Product, 2020 (E)
Figure 131: New Zealand Market Value Share, By End User, 2020 €
Figure 132: GCC Countries Market Value Analysis (US$ Mn), 2020 & 2030
Figure 133: GCC Countries Market Value Share, By Product, 2020 (E)
Figure 134: GCC Countries Market Value Share, By End User, 2020 (E)
Figure 135: Turkey Market Value Analysis (US$ Mn), 2020 & 2030
Figure 136: Turkey Market Value Share, By Product, 2020 (E)
Figure 137: Turkey Market Value Share, By End User, 2020 (E)
Figure 138: South Africa Market Value Analysis (US$ Mn), 2020 & 2030
Figure 139: South Africa Market Value Share, By Product, 2020 (E)
Figure 140: South Africa Market Value Share, By End User, 2020 (E)
Figure 141: Global Company Market Share Analysis, 2019
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Which region is the most attractive market for Diabetes Diagnostics Market?
North America is one of the most attractive markets for diabetes diagnostics.
Which segment to see huge demand in diabetes diagnostics market?
According to Fact.MR, the test strips segment is forecast to witness surging demand during 2020-2030.
Diabetes Diagnostics Market